Company: PCRX
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001396814-25-000102
Chunk: 51

Company: Pacira BioSciences, Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 1
Chunk 51
---
,932 $50,800 Work-in-process11,080 27,384 Finished goods96,151 47,098      Total$148,163 $125,282 In July 2025, the Company announced it decommissioned its 45-liter EXPAREL batch manufacturing suite located at its Science Center Campus in San Diego, California, and reduced its workforce accordingly. As a result, the Company reserved $1.0 million of raw materials during the six months ended June 30, 2025. For more information, see Note 18, Subsequent Events.

NOTE 6—FIXED ASSETS

Fixed assets, net, summarized by major category, consist of the following (in thousands):June 30,December 31,20252024Machinery and equipment$173,729 $160,643 Leasehold improvements97,408 86,034 Computer equipment and software25,232 23,473 Office furniture and equipment1,952 1,952 Construction in progress9,632 27,996         Total307,953 300,098 Less: accumulated depreciation(152,775)(132,929)        Fixed assets, net$155,178 $167,169 For the three months ended June 30, 2025 and 2024, depreciation expense was $13.0 million and $4.5 million, respectively. For the three months ended June 30, 2025 and 2024, there was none and $0.7 million of capitalized interest on the construction of manufacturing sites, respectively.For the six months ended June 30, 2025 and 2024, depreciation expense was $19.8 million and $8.6 million, respectively. For the six months ended June 30, 2025 and 2024, there was $0.1 million and $1.4 million of capitalized interest on the construction of manufacturing sites, respectively.As of June 30, 2025 and December 31, 2024, total fixed assets, net, includes manufacturing process equipment and leasehold improvements located outside of the U.S. in the amount of $50.1 million and $51.1 million, respectively. 

Pacira BioSciences, Inc.  |  Q2 2025 Form 10-Q  |  Page 16

As of both June 30, 2025 and December 31